In the News
Iya Khalil weighs in on AI in Real-World Drug Discovery
Following the recent Bio-IT conference, Iya Khalil and fellow keynote panelists weigh in on how AI is impacting real-world drug discovery efforts. Read the full article here.
read more
GNS CEO Colin Hill joins rank of Top 50 Healthcare Technology CEOs of 2019
The Healthcare Technology Report evaluates the hundreds of CEOs that lead exemplary organizations in the fields of medical devices, biotech, healthcare analytics, healthcare software and other related areas. They gather data on each nominee’s professional background...
read more
Adding Artificial Intelligence to Drug Discovery – Iya Khalil interviewed by GEN News
"AI is being used to really leverage learning from large-scale datasets, and those large-scale datasets are used to get to better novel targets." - Iya Khalil, GNS Co-Founder and COO, joins Mike May of Genetic Engineering & Biotechnology News to discuss AI in drug...
read more
GNS Co-founder, Iya Khalil interviewed by BioCentury: A Frequentist and a Bayesian Walk Into a Trial
GNS Co-Founder and COO Iya Khalil weighed in on the stand-off between Bayesians and frequentist. Read the full piece here.
read more
How A.I. Is Finding New Cures in Old Drugs
GNS CEO and Co-Founder Colin Hill is shares his thoughts on the stat of AI and biopharma with Fortune reporter Tiernan Ray. Read the full article here.
read more
GNS Co-Founder Iya Khalil Named to Forbes list of “50 Women-Led Startups That Are Crushing Tech”
GNS Co-Founder Iya Khalil joins 49 other female entrepreneurs who are pushing the frontiers of innovation across various industries. Read the full list here.
read more
GNS Co-Founder and CEO Colin Hill Discusses how AI will Power the Future of in silico Clinical Trials
GNS Co-Founder and CEO Colin Hill sat down with Outsourcing Pharma's Melissa Fassbender to discuss how in silico are making personalized medicine a reality. The interview covered how technology is driving pharma efforts to transition from resource-intensive trials to...
read more
GNS Co-Founder and CEO Colin Hill Discusses the transformation of “Big Data” in clinical informatics at the ChasmPartners Roundtable
GNS Co-Founder and CEO Colin Hill joined the ChasmPartners Roundtable to discuss the innovative approaches leveraging data and analytics being applied to drug development with Miki Kapoor, CEO of Verana Health, and Ken Tarkoff, CEO of Syapse. The conversation covered...
read more
Iya Khalil named one of Inc.’s Female Founders 100
When Iya Khalil founded GNS Healthcare with Colin Hill in 2000, the AI and machine learning in healthcare field was in its infancy. As a pioneer in the space, Iya has helped steer and shape the growth of data-driven healthcare and precision medicine. For this work,...
read more
GNS Healthcare Featured in Harvard Business Review Article on AI in the Workplace
GNS Healthcare is featured in the July/August issue of the Harvard Business Review as part of the article “Collaborative Intelligence: Humans and AI are Joining Forces”, a discussion of new digital tools and how AI can complement and augment human capabilities rather...
read more